相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural basis of inhibition of the human SGLT2-MAP17 glucose transporter
Yange Niu et al.
NATURE (2022)
Empagliflozin Enhances Autophagy, Mitochondrial Biogenesis, and Antioxidant Defense and Ameliorates Renal Ischemia/Reperfusion in Nondiabetic Rats
Moein Ala et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial
Rosalie A. Scholtes et al.
DIABETES CARE (2021)
Exploring the Role of CircRNA in Diabetic Kidney Disease from a Novel Perspective: Focusing on Both Glomeruli and Tubuli
Yuyuan Liu et al.
DNA AND CELL BIOLOGY (2021)
Mitochondrial quality control in kidney injury and repair
Chengyuan Tang et al.
NATURE REVIEWS NEPHROLOGY (2021)
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Giovanna Castoldi et al.
ACTA DIABETOLOGICA (2021)
Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin
Koenraad Philippaert et al.
CIRCULATION (2021)
Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
Hiddo J. L. Heerspink et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
Vincenzo Quagliariello et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis
Ana Karina Aranda-Rivera et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
Glenn M. Chertow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Chronic kidney disease
Kamyar Kalantar-Zadeh et al.
LANCET (2021)
Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway
Yi Quan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lipid peroxidation and ferroptosis: The role of GSH and GPx4
Fulvio Ursini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
Issei Tomita et al.
CELL METABOLISM (2020)
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z I Cherney et al.
Lancet Diabetes & Endocrinology (2020)
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
David C. Wheeler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2 Subgroup Analysis of the Randomized CREDENCE Trial
George Bakris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report
Cha Yang et al.
KIDNEY INTERNATIONAL (2020)
Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells
Markus Pirklbauer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Gene knockout of the Na+-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion
Josselin Nespoux et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension
Giovanna Castoldi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2020)
Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Oxidative stress in chronic kidney disease
Kristien Daenen et al.
PEDIATRIC NEPHROLOGY (2019)
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction
Salva R. Yurista et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
Kengo Kidokoro et al.
CIRCULATION (2019)
Potential protective effects of Dapagliflozin in gentamicin induced nephrotoxicity rat model via modulation of apoptosis associated miRNAs
Doaa I. Mohamed et al.
GENE (2019)
Using AMBER18 for Relative Free Energy Calculations
Lin Frank Song et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis
Yi Wen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury
Leyuan Xu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Targeting renal fibrosis: Mechanisms and drug delivery systems
Madalina V. Nastase et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Mechanisms of Renal Fibrosis
Benjamin D. Humphreys
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
Ablation of C/EBP homologous protein attenuates renal fibrosis after ureteral obstruction by reducing autophagy and microtubule disruption
Mi Ra Noh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion
Hua Liang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
Sarayut Lahnwong et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
Krit Jaikumkao et al.
DIABETES OBESITY & METABOLISM (2018)
Interleukin-1β Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis
Dario R. Lemos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Renal tubule injury: a driving force toward chronic kidney disease
Bi-Cheng Liu et al.
KIDNEY INTERNATIONAL (2018)
A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice
Yifan Zhang et al.
KIDNEY INTERNATIONAL (2018)
Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-kappa B in vivo and in vitro
Xiangjun Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Persistent activation of autophagy in kidney tubular cells promotes renal interstitial fibrosis during unilateral ureteral obstruction
Man J. Livingston et al.
AUTOPHAGY (2016)
Tubular Epithelial NF-κB Activity Regulates Ischemic AKI
Lajos Marko et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
L. A. Borthwick
SEMINARS IN IMMUNOPATHOLOGY (2016)
Cross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions
Xiaoxia Wang et al.
SCIENTIFIC REPORTS (2016)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Surviving apoptosis: life-death signaling in single cells
Deborah A. Flusberg et al.
TRENDS IN CELL BIOLOGY (2015)
The rheostat in the membrane: BCL-2 family proteins and apoptosis
N. Volkmann et al.
CELL DEATH AND DIFFERENTIATION (2014)
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats
Blanca Humanes et al.
KIDNEY INTERNATIONAL (2012)
MAMMALIAN MAPK SIGNAL TRANSDUCTION PATHWAYS ACTIVATED BY STRESS AND INFLAMMATION: A 10-YEAR UPDATE
John M. Kyriakis et al.
PHYSIOLOGICAL REVIEWS (2012)
Renal IL-18 Production Is Macrophage Independent During Obstructive Injury
Ethan I. Franke et al.
PLOS ONE (2012)
Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
Tingjun Hou et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
The role of Toll-like receptors in renal diseases
Anna Gluba et al.
NATURE REVIEWS NEPHROLOGY (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Robert L. Chevalier et al.
KIDNEY INTERNATIONAL (2009)
Mechanisms of renal apoptosis in health and disease
Ana Belen Sanz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity
Julie Chao et al.
HYPERTENSION (2007)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Structure and dynamics of liquid water with different long-range interaction truncation and temperature control methods in molecular dynamics simulations
P Mark et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)
Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
PA Kollman et al.
ACCOUNTS OF CHEMICAL RESEARCH (2000)
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy
G Grandaliano et al.
KIDNEY INTERNATIONAL (2000)
分享论文
